Skip to main content
. 2022 Jul 20;18(6):2095162. doi: 10.1080/21645515.2022.2095162

Table 4.

Relation of demographic variables and acceptance for a booster dose.

Variables Acceptance
Hesitation for the booster dose
p-value Recommend others to get the booster dose at the earliest
p-value Preference to develop natural immunity by infection
p-value
Yes (%) No (%) Yes (%) No (%) Yes (%) No (%)
Area of residency Rural 60(55.0%) 49(45.0%) .110NS 56(51.4%) 53(48.6%) .027* 54(49.5%) 55(50.5%) .564NS
Urban 233(46.6%) 267(53.4%) 314(62.8%) 186(37.2%) 232(46.5%) 267(53.5%)
Age (in yrs) <20 14(45.2%) 17(54.8%) .722NS 22(71.0%) 9(29.0%) .474NS 11(35.5%) 20(64.5%) .400NS
20 - 39 176(47.4%) 195(52.6%) 227(61.2%) 144(38.8%) 182(49.2%) 188(50.8%)
40 - 59 91(48.7%) 96(51.3%) 111(59.4%) 76(40.6%) 83(44.4%) 104(55.6%)
> = 60 12(60.0%) 8(40.0%) 10(50.0%) 10(50.0%) 10(50.0%) 10(50.0%)
Gender Male 124(42.8%) 169(53.0%) .012* 199(68.6%) 171(53.6%) <.001* 135(46.7%) 151(47.3%) .878NS
Female 169(53.0%) 150(47.0%) 91(31.4%) 148(46.4%) 154(53.3%) 168(52.7%)
Education Primary 6(30.0%) 14(70.0%) .056NS 15(75.0%) 5(25.0%) .280NS 10(50.0%) 10(50.0%) .179NS
Secondary 34(50.7%) 33(49.3%) 46(68.7%) 21(31.3%) 29(43.3%) 38(56.7%)
Diploma 97(55.4%) 78(44.6%) 99(56.6%) 76(43.4%) 93(53.1%) 82(46.9%)
Graduate 121(46.7%) 138(53.3%) 159(61.4%) 100(38.6%) 121(46.9%) 33(37.5%)
Postgraduate 35(39.8%) 53(60.2%) 51(58.0%) 37(42.0%) 137(53.1%) 55(62.5%)

P-value for Chi-square test. P-value <.05 is considered to be statistically significant.

*P-value <.05, **P-value <.001, NS-statistically non-significant, higher mean score indicates a higher level of knowledge and vice-versa.